Faculty profile

Lambert Busque

ResearcherMédecineUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.

Lambert Busque

Researcher

Médecine

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
24 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2018.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

523

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Leukemia Biomarkers Aiging Cardiovascular Disease Clonal Hematopoiesis Inflammation Microbiota Cancer

Latest papers

Reversible Neutrophilia Driven by Monoclonal Gammopathy of Clinical Significance Simulating Chronic Neutrophilic Leukemia: A Case Report.
Case reports in hematology · 2026
MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms.
Blood advances · 2026
Low-Dose Colchicine Attenuates Clonal Hematopoiesis in COLCOT.
Circulation · 2026

All 63 publications

Latest funding

COLCOT-T2D : Colchicine for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes
CIHR · 2020 · Co-investigator
$5,446,800
Determining the etiologies of age-related clonal hematopoiesis (ARCH), a new biomarker of cancer and cardiovascular disease development: focus on the roles of inflammation and genetic predisposition.
CIHR · 2018 · Nominated PI
$956,250
C3i - Centre for commercialization of Cancer Immunotherapy
CIHR · 2015 · Nominated PI
$10,515,000

All 6 grants and awards

63 publications.

Reversible Neutrophilia Driven by Monoclonal Gammopathy of Clinical Significance Simulating Chronic Neutrophilic Leukemia: A Case Report.

Larin É, Busque L, Chabot-Roy G, Lesage S, Jadot G, LeBlanc R, Roy J, Claveau JS, Szuber N

Case reports in hematology2026

DOI: 10.1155/crh/7405586 PMID: 42630736

MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms.

Ouellet M, Rizzolo A, Venne C, Moussa H, Bilodeau K, Mollica L, Chabot-Roy G, Huynh-Trudeau G, Lesage S, Harnois M, Busque L, Sirhan S, Szuber N

Blood advances2026

DOI: 10.1182/bloodadvances.2025018682 PMID: 41499761

Low-Dose Colchicine Attenuates Clonal Hematopoiesis in COLCOT.

Tardif JC, Busque L, Geoffroy S, Sandoval J, Lemieux Perreault LP, Mongrain I, Gagnon MF, Valois D, Gaulin-Marion MJ, Buscarlet M, Maggioni AP, Kouz S, Pinto FJ, Lopez-Sendon J, Waters DD, Diaz R, Gamra H, Kiwan GS, Berry C, Koenig W, Grégoire JC, L'Allier PL, Provencher M, Guertin MC, Roubille F, Oussaïd E, Barhdadi A, Dubé MP

Circulation2026

DOI: 10.1161/circulationaha.125.077665 PMID: 41730026

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Schweitzer L, Thiant S, Thérien C, Giroux M, Lachance S, Fleury I, Orio J, Carli C, Boudreau G, Patenaude J, Tremblay-Laganière C, Senécal L, Dufresne SF, Mollica L, Collette S, Sauvageau G, Kiss T, Cohen S, Bernard L, Bambace N, Veilleux O, Ahmad I, Roy J, Busque L, Duval M, Bittencourt H, Teira P, Lamarche C, Roy DC, Delisle JS

Open forum infectious diseases2026

DOI: 10.1093/ofid/ofag006 PMID: 41614086

Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study.

Koschmieder S, Schulte C, von der Heyde E, Busque L, Boyer-Perrard F, Devos T, Passamonti F, Cheng WY, Cheng M, Nuortti M, Baum V, Harrison C

Therapeutic advances in hematology2025

DOI: 10.1177/20406207251342199 PMID: 40620727

Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact-a study of 784 patients from the Quebec MPN research group.

Poullet A, Busque L, Sirhan S, Delage R, Cournoyer G, Chamakhi I, Talbot D, Mollica L, Marceau D, Ethier V, Desjardins P, Olney HJ, Harnois M, Szuber N

Blood cancer journal2025

DOI: 10.1038/s41408-025-01234-8 PMID: 40169545

Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health survey.

Harrison CN, Ross DM, Fogliatto LM, Foltz L, Busque L, Xiao Z, Heidel FH, Koehler M, Palumbo GA, Breccia M, Komatsu N, Kirito K, Xicoy Cirici B, Martinez-Lopez J, Rovo A, Petruk C, Bobirca C, Mirams L, McMillan A, Harper G, Kiladjian JJ

HemaSphere2025

DOI: 10.1002/hem3.70106 PMID: 40130070

Fibrosis and treatment-free remission in chronic myeloid leukaemia.

Brailovski E, Harnois M, Busque L, Chamakhi I, Tremblay A, Desjardins P, Assouline S

British journal of haematology2025

DOI: 10.1111/bjh.19995 PMID: 39948763

Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non-standardized approach.

Terra R, Éthier V, Busque L, Morin-Quintal A, D'Angelo G, Hébert J, Wang X, Lépine G, LeBlanc R, Bergeron J

Cytometry. Part B, Clinical cytometry2025

DOI: 10.1002/cyto.b.22213 PMID: 39538364

Perioperative outcomes in patients with myeloproliferative neoplasms: a multicentric analysis of 354 surgical procedures.

Szuber N, Olney HJ, Dagenais Bellefeuille S, Tanguay M, Shehabeldeen A, Ahmed S, Harnois M, Prchal J, Busque L, Sirhan S

Blood vessels, thrombosis & hemostasis2024

DOI: 10.1016/j.bvth.2024.100026 PMID: 40765935

Something wrong or missing on this profile? Suggest a correction

Lambert Busque

Research

Latest papers

Latest funding

Reversible Neutrophilia Driven by Monoclonal Gammopathy of Clinical Significance Simulating Chronic Neutrophilic Leukemia: A Case Report.

MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms.

Low-Dose Colchicine Attenuates Clonal Hematopoiesis in COLCOT.

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.

Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study.

Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact-a study of 784 patients from the Quebec MPN research group.

Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health survey.

Fibrosis and treatment-free remission in chronic myeloid leukaemia.

Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non-standardized approach.

Perioperative outcomes in patients with myeloproliferative neoplasms: a multicentric analysis of 354 surgical procedures.

COLCOT-T2D : Colchicine for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes

Determining the etiologies of age-related clonal hematopoiesis (ARCH), a new biomarker of cancer and cardiovascular disease development: focus on the roles of inflammation and genetic predisposition.

C3i - Centre for commercialization of Cancer Immunotherapy

Relationship between clonal architecture of aging hematopoiesis and the risk of developing age-associated myeloid cancers.

Psychological burden and pathological aging in individuals with and without cardiovascular disease

Pharmacogenetic study of warfarin

Frequent collaborators

Jean Roy

Denis-Claude Roy

Guy Sauvageau

Jean-Claude Tardif

Jean-Claude Tardif

Sandra Cohen

Brian Leber

Claude Perreault

Tracy Stockley

Laurent Azoulay

Laurent Azoulay

Sylvie Lesage

Caroline Lamarche

Caroline Hamm

Christopher Hillis

Francis Rodier

Thao Huynh

Simon De Denus

Anne Marinier

Alain Deschamps

Karine Bilodeau

Martin Pelletier

Heather Galipeau

Guy Boivin

Elena Verdu